Drugs / Lu AF95245
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04199585 | Dec 2019 → Feb 2020 | — | H. Lundbeck A/S | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF95245 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04199585 ↗ |
| Route | Oral | “solution, single dose, orally” NCT04199585 ↗ |